drugset / Trial / NCT03758079

Comparison of Gabapentin With Doxepin in the Management of Uremic Pruritus

NCT03758079

Phase 4 Completed 14 enrolled University of Balamand
RandomizedCrossoverSingle-blindTreatment

Summary

This is a single blind randomized trial to compare efficacy and side effects of Gabapentin with Doxepin. Hemodialysis patients with uremic pruritus at one dialysis center of Saint George Hospital University Medical Centre were included in this study. Patients were divided into 2 groups to receive either 10 mg Doxepin daily or Gabapentin at a dose of 100mg after each hemodialysis session (increased as tolerated) for 4 weeks, after which patients were treated reversley. Pruritus severity and its effect on quality of life will be assessed by using visual analog scale (VAS), 5-D pruritus scale and dermatology life quality index (DLQI). Include patients will have to fill these forms at baseline and at end of week1, week2 and week4

Timeline

Start
2018-06-01
Primary completion
2018-10-08
Completion
2018-10-08

Drugs

EvaluationDrugModalityDoseRoute
Comparator Doxepin Unknown 10 mg
Comparator Gabapentin Small molecule 100 mg

Indications

No indication recorded.